[HTML][HTML] Is antioxidant therapy a useful complementary measure for Covid-19 treatment? An algorithm for its application

ME Soto, V Guarner-Lans, E Soria-Castro… - Medicina, 2020 - mdpi.com
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes the corona virus
disease-19 which is accompanied by severe pneumonia, pulmonary alveolar collapses and …

Pentoxifylline for treatment of sepsis and necrotising enterocolitis in neonates

M Pammi, KN Haque - Cochrane Database of Systematic …, 2023 - cochranelibrary.com
Background Mortality and morbidity due to neonatal sepsis and necrotising enterocolitis
(NEC) remain high despite the use of potent antimicrobial agents. Agents that modulate …

[HTML][HTML] Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19

AP Chavarría, RRV Vázquez, JGD Cherit… - Computational and …, 2021 - Elsevier
The type 2 coronavirus causes severe acute respiratory syndrome (SARS-CoV-2) and
produces pneumonia with pulmonary alveolar collapse. In some cases it also causes sepsis …

Sepsis and oxidative stress in the newborn: from pathogenesis to novel therapeutic targets

C Poggi, C Dani - Oxidative medicine and cellular longevity, 2018 - Wiley Online Library
Sepsis is at present one of the leading causes of morbidity and mortality in the neonatal
population. Together with inflammation, oxidative stress is involved in detrimental pathways …

[HTML][HTML] Immunomodulation to prevent or treat neonatal sepsis: past, present, and future

SS Schüller, BW Kramer, E Villamor, A Spittler… - Frontiers in …, 2018 - frontiersin.org
Despite continued advances in neonatal medicine, sepsis remains a leading cause of death
worldwide in neonatal intensive care units. The clinical presentation of sepsis in neonates …

[HTML][HTML] Phosphodiesterase inhibitors in acute lung injury: what are the perspectives?

D Mokra, J Mokry - International Journal of Molecular Sciences, 2021 - mdpi.com
Despite progress in understanding the pathophysiology of acute lung damage, currently
approved treatment possibilities are limited to lung-protective ventilation, prone positioning …

[HTML][HTML] Contemporary trends in global mortality of sepsis among young infants less than 90 days: a systematic review and meta-analysis

MY Gan, WL Lee, BJ Yap, STT Seethor… - Frontiers in …, 2022 - frontiersin.org
Objective Current knowledge on the global burden of infant sepsis is limited to population-
level data. We aimed to summarize global case fatality rates (CFRs) of young infants with …

[HTML][HTML] Neonatal sepsis: a systematic review of core outcomes from randomised clinical trials

CJ Henry, G Semova, E Barnes, I Cotter, T Devers… - Pediatric …, 2022 - nature.com
Background The lack of a consensus definition of neonatal sepsis and a core outcome set
(COS) proves a substantial impediment to research that influences policy and practice …

Immunometabolic approaches to prevent, detect, and treat neonatal sepsis

MG Conti, A Angelidou, J Diray-Arce, KK Smolen… - Pediatric …, 2020 - nature.com
The first days of postnatal life are energetically demanding as metabolic functions change
dramatically to accommodate drastic environmental and physiologic transitions after birth. It …

[HTML][HTML] Pentoxifylline inhibits TLR-and inflammasome-mediated in vitro inflammatory cytokine production in human blood with greater efficacy and potency in …

EM Speer, DJ Dowling, LS Ozog, J Xu, J Yang… - Pediatric …, 2017 - nature.com
Background: Toll-like receptor (TLR)-mediated inflammation may contribute to neonatal
sepsis, for which pentoxifylline (PTX), a phosphodiesterase inhibitor that raises intracellular …